Synthesis and cholera toxin binding properties of multivalent GM1 mimics.
暂无分享,去创建一个
Anna Bernardi | A. Bernardi | R. Liskamp | R. Pieters | D. Arosio | Daniela Arosio | Rob M J Liskamp | Paola Valentini | Roland J Pieters | Ioannis Vrasidas | Ioannis Vrasidas | P. Valentini
[1] E. Toone,et al. Multivalency effects in protein--carbohydrate interaction: the binding of the Shiga-like toxin 1 binding subunit to multivalent C-linked glycopeptides. , 2000, The Journal of organic chemistry.
[2] J Fraser Stoddart,et al. Design and synthesis of glycodendrimers. , 2002, Journal of biotechnology.
[3] M. Fischer,et al. Kinetic analysis of the mass transport limited interaction between the tyrosine kinase lck SH2 domain and a phosphorylated peptide studied by a new cuvette-based surface plasmon resonance instrument. , 2000, Analytical biochemistry.
[4] Second generation mimics of ganglioside GM1 as artificial receptors for cholera toxin: replacement of the sialic acid moiety. , 2000, Bioorganic & medicinal chemistry letters.
[5] R. Roy. A Decade of Glycodendrimer Chemistry , 2003 .
[6] E. Toone,et al. The cluster glycoside effect. , 2002, Chemical reviews.
[7] C. Verlinde,et al. Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin. , 2002, Journal of the American Chemical Society.
[8] P. Kitov,et al. On the nature of the multivalency effect: a thermodynamic model. , 2003, Journal of the American Chemical Society.
[9] P. Seneci,et al. Stereoselective synthesis of conformationally constrained cyclohexanediols: a set of molecular scaffolds for the synthesis of glycomimetics. , 2001, The Journal of organic chemistry.
[10] S. Homans,et al. Optimization of tether length in nonglycosidically linked bivalent ligands that target sites 2 and 1 of a Shiga-like toxin. , 2003, Journal of the American Chemical Society.
[11] S. Homans,et al. Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry. , 2004, Journal of the American Chemical Society.
[12] R. Ball,et al. Absolute Stereochemistry of the Squalene Synthase Inhibitor Zaragozic Acid C , 1994 .
[13] R. Read,et al. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.
[14] C. Verlinde,et al. AB(5) toxins: structures and inhibitor design. , 2000, Current opinion in structural biology.
[15] S. Sonnino,et al. The anti-oligosaccharide antibodies present in sera from patients with motor neuron disease and neuropathy recognize theN-glycolylneuraminic acid containing gangliotetrahexosyl oligosaccharide , 1995, Glycoconjugate Journal.
[16] J. McCann,et al. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin B subunit. , 1996, Biochemical and biophysical research communications.
[17] L. Kiessling,et al. Synergistic Formation of Soluble Lectin Clusters by a Templated Multivalent Saccharide Ligand , 2000 .
[18] A. Bernardi,et al. Mimicking Gangliosides by Design: Mimics of GM1 Headgroup , 2002, Neurochemical Research.
[19] George M. Whitesides,et al. Design, Synthesis, and Characterization of a High-Affinity Trivalent System Derived from Vancomycin and l-Lys-d-Ala-d-Ala , 2000 .
[20] W. Hol,et al. Characterization and crystal structure of a high-affinity pentavalent receptor-binding inhibitor for cholera toxin and E. coli heat-labile enterotoxin. , 2002, Journal of the American Chemical Society.
[21] Sandro Sonnino,et al. Sugar Mimics: An Artificial Receptor for Cholera Toxin , 1999 .
[22] Ji Young Kim,et al. Multivalent Inhibition of AB5 Toxins , 2001 .
[23] Yuan-chuan Lee,et al. Affinity enhancement by multivalent lectin–carbohydrate interaction , 2000, Glycoconjugate Journal.
[24] Ganglioside GM1 mimics: lipophilic substituents improve affinity for cholera toxin. , 2003, Bioorganic & medicinal chemistry letters.
[25] W. Hol,et al. High-Affinity Pentavalent Ligands of Escherichia coli Heat-Labile Enterotoxin by Modular Structure-Based Design , 2000 .
[26] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.